Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abbvie, Abelzeta, ADC, Akeso, Amplia, Ascentage, Astrazeneca, Biocryst, BMS, Brainstorm, Clarametyx, D&D, Eolo, Genmab, Halia, Incyte, Intellia, Janssen-Cilag, Jasper, Johnson, Kalvista, Lantern, Pharvaris, Regeneron, Roche, Sanofi, Sarepta, Tonix, Windtree, X4.